We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Alps Dx Debuts Oral Fluid Sample Preparation Device at ADLM 2026

By LabMedica International staff writers
Posted on 28 Jul 2026

Alps Dx (Richmond, VA, USA) is participating in the ADLM 2026 Annual Meeting & Clinical Lab Expo, taking place July 26–30 at the Anaheim Convention Center in California. More...

The company is debuting Xpressor by Alps Dx, a filtration and capping device designed to improve oral fluid sample quality and preanalytical efficiency, alongside its Atelier automated processing platform.

Xpressor is designed to address long-standing challenges in forensic and clinical toxicology laboratories, where oral fluid sample preparation can involve several manual handling steps. Conventional processes may require technicians to squeeze collection swabs by hand, change gloves between specimens, transfer samples into new tubes, or perform centrifugation, increasing processing time and the potential for contamination, variability, and sample loss.

The device simplifies oral fluid preparation into two steps. After opening the collection tube, the technician inserts the Xpressor filter and cap, allowing filtration to occur inside the original tube rather than requiring the sample to be transferred to a separate container. This approach is intended to preserve the original chain-of-custody tube while reducing manual intervention.

Alps Dx notes that early independent studies indicate that Xpressor requires less handling and produces more consistent sample clarity than traditional preparation methods. Laboratories using the device have also reported fewer glove changes, reduced contamination risk, improved traceability, and shorter processing times. The system may additionally reduce sample loss and consumable use, supporting cost-control and sustainability goals.

Visitors can also explore Atelier by Alps Dx, a scalable, high-throughput platform that automates labor-intensive oral fluid sample handling and preparation. The system is designed to improve workflow efficiency and traceability while reducing manual processes and the potential for human error. It is offered through a subscription model that allows laboratories to expand automation without an upfront capital investment.

Together, Xpressor and Atelier form part of the company’s connected approach to modernizing the oral fluid preanalytical workflow. Alps Dx is expanding its portfolio of instruments, consumables, workflow software, and mobile technologies to support oral fluid specimens from collection through laboratory analysis.


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Pathology

view channel
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.